Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048

Terminated

Phase 2 Results

Summary of Purpose

To determine the long term safety and efficacy of BIBR 1048 in patients with chronic atrial fibrilla tion, with or without concomitant chronic treatment with acetylsalicylic acid (ASA).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 8 May 2014.

1 Dec 2003 8 Sep 2005 1 Jan 2009 Unavailable 1 Feb 2014 18 Nov 2010
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study

Contacts

Not available